Higher Semaglutide Dose Shows Stronger Weight Loss Benefits, Study Finds
A weekly 7.2 mg dose of semaglutide is safe and significantly aids weight loss in adults with obesity, including those with type 2 diabetes.
Research Presented At ENDO 2025 Shows IER Offers Metabolic Advantages
Intermittent energy restriction improves blood sugar and insulin sensitivity in obese diabetics, study finds; presented at ENDO.
Increased Premature Birth Risk Linked To Liver Disease In Pregnant Women
A recent study highlighted a concerning link between metabolic dysfunction steatotic liver disease and an increased risk of premature birth.
Diabetes Drug Shows Promise In Slowing Prostate Cancer Growth, Study Finds
A drug used to treat type 2 diabetes may also help slow the growth of prostate cancer, according to a new study.
US Is Dying Of Type 2 Diabetes; Here’s The Solution For The Same From US Food And Drug Administration
Danone filed an application for the claim with the FDA after Blechman referenced a 2014 study from the Department of Nutrition at the Harvard School of Public Health, which indicated a higher intake of yogurt is linked to type 2 diabetes.
Type One Diabetes As A Global Burden
The people living with Type 1 Diabetes (T1D) are around 8.4 million across the globe, according to the results of a new modeling study published in The Lancet Diabetes & Endocrinology. This number is said to be increasing from 13.5 to 17.4 million people living with T1D by the year 2040. “Given that prevalence of …